MEDINA is an independent and non profit entity with innovative research collaborations and contracts with academic and industrial partners worldwide. We are engaged in the discovery of novel drug candidates and new biomarkers with Pharma and Biotech companies and research groups, as well as of new biotechnological products for use in crop protection for the Agrofood industry, Consumer products (Cosmetic and Nutrition) and new enzymes for industrial processes. MEDINA owns one of the largest Collections of Microbial Strains and the most chemically diverse Natural Products Libraries with a longstanding, successful track record in delivering novel drug candidates for development as pharmaceuticals. Our team has unique expertise in natural products microbiology, chemistry, high throughput screening, as well as a strong analytical chemistry platform for molecular structure elucidation and bioanalysis. We are currently active in drug and biomarker discovery programs in infectious diseases (including tuberculosis and parasitic diseases), cancer, CNS, and rare diseases. Leveraging our unique strengths in high precision-high throughput analytics and bioanalytics we are collaborating with clinical investigators in translational research programs for biomarker discovery and metabolomic profiling of patient samples. MEDINA is a Research Organization established in the Health Sciences Technology Park, Granada (Spain) as a private-public partnership between the Government of Andalucía (Spain), the University of Granada and Merck Sharp and Dohme de España S.A.